Pharmaceutical inhibition of CTSB improves lysosomal function and decreases viral release, eventually leading to mitigated AP pathology (Fig. 4, 5 and 7), demonstrating a detrimental role of CTSB activation in viral AP. The gene discussed is CTSB; the disease is alkaline phosphatase measurement.